HEAD AND NECK NEOPLASMS
Clinical trials for HEAD AND NECK NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new HEAD AND NECK NEOPLASMS trials appear
Sign up with your email to follow new studies for HEAD AND NECK NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Cancer combo trial pulled before it even started
Disease control TerminatedThis study was designed for people with advanced head and neck cancer that had spread or come back. It aimed to test a combination of two drugs: decitabine (a chemotherapy drug) and nivolumab (an immunotherapy drug). The goal was to see if the combination was safe and could help …
Matched conditions: HEAD AND NECK NEOPLASMS
Phase: PHASE1 • Sponsor: Case Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New drug AZD9592 enters first human trials for tough cancers
Disease control OngoingThis early-stage trial tests an experimental drug called AZD9592, alone or with other cancer drugs, in about 167 adults with advanced solid tumors (including lung, head & neck, and colorectal cancers). The main goals are to check safety, find the right dose, and see if the drug s…
Matched conditions: HEAD AND NECK NEOPLASMS
Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Experimental drug targets HER2-Positive tumors in multiple cancers
Disease control OngoingThis phase 2 trial tests an experimental drug called disitamab vedotin in people with advanced head and neck, lung, endometrial, or ovarian cancers that have a protein called HER2. The drug is designed to stick to cancer cells and kill them. Researchers want to see if it shrinks …
Matched conditions: HEAD AND NECK NEOPLASMS
Phase: PHASE2 • Sponsor: Seagen, a wholly owned subsidiary of Pfizer • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New drug targets rare gene fusions in multiple cancers
Disease control OngoingThis phase 2 study tests the drug entrectinib in over 500 people with advanced solid tumors that have specific gene changes (NTRK, ROS1, or ALK fusions). The goal is to see if the drug can shrink tumors and control the disease. Participants have various cancer types, including lu…
Matched conditions: HEAD AND NECK NEOPLASMS
Phase: PHASE2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Immunotherapy combo may keep head and neck cancer at bay
Disease control OngoingThis phase 3 trial tests whether adding the immunotherapy drug pembrolizumab before and after surgery can help people with advanced head and neck cancer stay cancer-free longer. About 714 participants receive either pembrolizumab plus standard radiation (with or without chemo) or…
Matched conditions: HEAD AND NECK NEOPLASMS
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Engineered immune cells take on advanced cancers in early trial
Disease control OngoingThis early-phase study tests whether a new treatment called KSQ-001EX is safe for people with advanced solid tumors like melanoma, lung cancer, or head and neck cancer. The treatment uses a patient's own immune cells (tumor-infiltrating lymphocytes) that are genetically modified …
Matched conditions: HEAD AND NECK NEOPLASMS
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Can a simple fluoride treatment save teeth after cancer radiation?
Symptom relief OngoingThis pilot study looks at whether giving fluoride varnish during regular cancer checkups can help protect the teeth of head and neck cancer patients who have had radiation and lack easy access to a dentist. About 43 uninsured or underinsured adults will receive 4-5 fluoride treat…
Matched conditions: HEAD AND NECK NEOPLASMS
Phase: NA • Sponsor: University of California, San Francisco • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Amazonian tree oil may soothe radiation mouth sores in cancer patients
Symptom relief OngoingThis early-phase study tests whether a mouthwash made from copaiba, a natural oil from the Amazon, can safely help prevent and treat painful mouth sores caused by radiation therapy in 20 adults with head and neck cancer. Researchers will find the highest safe dose and measure pai…
Matched conditions: HEAD AND NECK NEOPLASMS
Phase: PHASE1 • Sponsor: Instituto Nacional de Cancer, Brazil • Aim: Symptom relief
Last updated Jun 27, 2026 12:28 UTC
-
Robotic surgery or radiation? new study compares which is better for throat cancer patients' quality of life
Symptom relief OngoingThis study compares two treatments for early-stage throat cancer: robotic surgery (TORS) or radiation therapy (IMRT). It looks at which one leads to better swallowing function and overall quality of life. About 138 adults with HPV-related throat cancer are taking part. The goal i…
Matched conditions: HEAD AND NECK NEOPLASMS
Phase: NA • Sponsor: Christian von Buchwald • Aim: Symptom relief
Last updated Jun 27, 2026 08:07 UTC
-
Can radiation help kick the habit? new study explores smoking cessation in cancer patients
Knowledge-focused OngoingThis study follows 100 head and neck or lung cancer patients who are current or former smokers and receive radiation therapy. Researchers track who stays smoke-free at 1, 6, and 12 months after treatment ends, and what factors help or hinder abstinence. The goal is to learn how t…
Matched conditions: HEAD AND NECK NEOPLASMS
Sponsor: Centre Oscar Lambret • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC
-
Online prep program for head & neck surgery patients fails to launch
Knowledge-focused TerminatedThis study aimed to see if a personalized online education program could help people having major head or neck surgery feel more prepared and satisfied, and reduce trips to the hospital. The study was withdrawn before any participants were enrolled, so no results are available.
Matched conditions: HEAD AND NECK NEOPLASMS
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:56 UTC